These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23316664)

  • 1. [Psoriasis and cardiovascular risk factors].
    Tal R; Pavlovsky L; David M
    Harefuah; 2012 Oct; 151(10):573-5, 605. PubMed ID: 23316664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular and Metabolic Diseases Comorbid with Psoriasis: Beyond the Skin.
    Furue M; Tsuji G; Chiba T; Kadono T
    Intern Med; 2017; 56(13):1613-1619. PubMed ID: 28674347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart disease in psoriasis.
    Kremers HM; McEvoy MT; Dann FJ; Gabriel SE
    J Am Acad Dermatol; 2007 Aug; 57(2):347-54. PubMed ID: 17433490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular health for patients with psoriasis: a précis for front-line clinicians.
    Federman DG; Shelling ML; Prodanovich S; Gunderson CG; Kirsner RS
    Ostomy Wound Manage; 2009 May; 55(5):38-47. PubMed ID: 19471047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Is psoriasis a dependent cardiovascular risk factor?].
    Wakkee M; de Jong EM
    Ned Tijdschr Geneeskd; 2013; 157(11):A5417. PubMed ID: 23484510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk and psoriasis: beyond the traditional risk factors.
    Coumbe AG; Pritzker MR; Duprez DA
    Am J Med; 2014 Jan; 127(1):12-8. PubMed ID: 24161194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More than skin deep: atherosclerosis as a systemic manifestation of psoriasis.
    Alexandroff AB; Pauriah M; Camp RD; Lang CC; Struthers AD; Armstrong DJ
    Br J Dermatol; 2009 Jul; 161(1):1-7. PubMed ID: 19500102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of the framingham risk score in patients with chronic psoriasis.
    Gisondi P; Farina S; Giordano MV; Girolomoni G
    Am J Cardiol; 2010 Dec; 106(12):1754-7. PubMed ID: 21055711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoriasis: the visible killer.
    Torres T; Bettencourt N
    Rev Port Cardiol; 2014 Feb; 33(2):95-9. PubMed ID: 24525359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasis comorbidities.
    Gottlieb AB; Chao C; Dann F
    J Dermatolog Treat; 2008; 19(1):5-21. PubMed ID: 18273720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk and psoriasis: the role of biologic therapy.
    Puig L
    Actas Dermosifiliogr; 2012 Dec; 103(10):853-62. PubMed ID: 23157913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and potential pathomechanisms of cardiovascular comorbidities in psoriasis: a report from the GRAPPA 2010 annual meeting.
    Boehncke WH
    J Rheumatol; 2012 Feb; 39(2):441-4. PubMed ID: 22298277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 17, inflammation, and cardiovascular risk in patients with psoriasis.
    Lockshin B; Balagula Y; Merola JF
    J Am Acad Dermatol; 2018 Aug; 79(2):345-352. PubMed ID: 29477740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular morbidity in psoriasis: epidemiology, pathomechanisms, and clinical consequences.
    Boehncke WH; Boehncke S
    G Ital Dermatol Venereol; 2008 Oct; 143(5):307-13. PubMed ID: 18833072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriasis and cardiovascular diseases.
    Vizzardi E; Raddino R; Teli M; Gorga E; Brambilla G; Dei Cas L
    Acta Cardiol; 2010 Jun; 65(3):337-40. PubMed ID: 20666273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic plaque psoriasis is associated with increased arterial stiffness.
    Gisondi P; Fantin F; Del Giglio M; Valbusa F; Marino F; Zamboni M; Girolomoni G
    Dermatology; 2009; 218(2):110-3. PubMed ID: 19060461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic comorbidities and psoriasis.
    Gisondi P; Ferrazzi A; Girolomoni G
    Acta Dermatovenerol Croat; 2010; 18(4):297-304. PubMed ID: 21251450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients.
    Wakkee M; Thio HB; Prens EP; Sijbrands EJ; Neumann HA
    Atherosclerosis; 2007 Jan; 190(1):1-9. PubMed ID: 16942772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriasis: an opportunity to identify cardiovascular risk.
    Federman DG; Shelling M; Prodanovich S; Gunderson CG; Kirsner RS
    Br J Dermatol; 2009 Jan; 160(1):1-7. PubMed ID: 19016698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AJC editor's consensus: psoriasis and coronary artery disease.
    Friedewald VE; Cather JC; Gelfand JM; Gordon KB; Gibbons GH; Grundy SM; Jarratt MT; Krueger JG; Ridker PM; Stone N; Roberts WC
    Am J Cardiol; 2008 Dec; 102(12):1631-43. PubMed ID: 19064017
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.